Identification of Biomarkers in Cervical Mucus

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age18-45
SponsorFondazione Policlinico Universitario Agostino Gemelli IRCCS

About this trial

Cervical mucus is a biological fluid secreted by the endocervical glandular epithelium whose quantitative and qualitative characteristics vary in response to the hormonal stimulus produced by the ovary during the woman's menstrual cycle. As a fertility factor, it performs numerous biological functions: transport, nourishment, defense and capacitation of spermatozoa, defense against pathogens of the female genital tract.

The aim of this research will be to deepen the knowledge of the biochemical characteristics of cervical mucus, in particular to perform characterization by infrared spectroscopy, for the identification of diagnostic, prognostic and predictive biomarkers for disorders affecting the female reproductive system.

A healthy control population and a cohort of patients affected by unexplained infertility will be enrolled for the longitudinal study of the menstrual cycle with ultrasound and hormonal monitoring and serial sampling of cervical mucus.

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

HEALTHY CONTROL

Women of 18-45 years old,

Use of the Billings Ovulation Method® for at least three months in the last three years

Proven fertility

Disqualifiers

Virgo women

Women incapable of understanding and wanting

Women who have had sexual intercourse in the two days prior to cervical mucus sampling

Pregnancy, exclusive breastfeeding

Trial design

Design model

Single group

Treatments tested in this trial

  • cervical mucus sampling

    Diagnostic test

    Monitoring of menstrual cycle will be conducted in the follicular, ovulatory and luteal phases during which cervical mucus, serum and urine samples will be collected and pelvic ultrasound scans performed (3-5 ultrasound scans/samples within the cycle).

Treatment groups

24 Participants
are divided into 1 treatment group
Group A: CERVICAL MUCUS ANALYSISOther 1 intervention

Trial outcomes

Primary outcomes

1

Characterization by infrared spectroscopy of cervical mucus

Analysis of the spectra as revealed using by infrared spectroscopy on samples of cervical mucus. Analysis of their variations during the different phases of the menstrual cycle in cases group vs healthy controls groups.

Time frame
1 month (3 time points within a menstrual cycle)

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.